Agusto Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 55.12%
- Profit Growth -36.50%
- Ebitda 67.40%
- Net Worth 19.38%
- Total Assets 36.41%
About Agusto Formulations
Agusto Formulations Private Limited (AFPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2018 (Six years and ten months 25 days old ). Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhiren Surjiani, Naresh Surjiani, and Ravi Verma serve as directors at the Company.
Company Details
-
Location
Valsad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15549GJ2018PTC101341
-
Company No.
101341
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Mar 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Agusto Formulations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Surjiani
|
Director | 16-Mar-2018 | Current |
|
Dhiren Surjiani
|
Director | 16-Mar-2018 | Current |
|
Ravi Verma
|
Director | 16-Mar-2018 | Current |
Financial Performance of Agusto Formulations.
Agusto Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.12% increase. The company also saw a substantial fall in profitability, with a 36.5% decrease in profit. The company's net worth Soared by an impressive increase of 19.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agusto Formulations?
In 2023, Agusto Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Frespresso Hospitality Private LimitedDhiren Surjiani and Naresh Surjiani are mutual person
-
Stravia Trendz LlpDhiren Surjiani and Ravi Verma are mutual person
-
Venera Logistics Private Limited
Ravi Verma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agusto Formulations?
Agusto Formulations has a workforce of 60 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agusto Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agusto Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
